Di Ke
Impact in
-
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Plant biochemistry and biosynthesis
- Cancer-related gene regulation
- Microbial Metabolic Engineering and Bioproduction
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Chemical Synthesis and Analysis 3
- Plant biochemistry and biosynthesis 2
-
- Ferroptosis and cancer prognosis 5
- Co-authors
- Guojun Jiang (2 shared papers)Dan Li (1 shared paper)Wenyu Lü (3 shared papers)Kai Li (1 shared paper)Wei Zhang (1 shared paper)Xue Xiao (3 shared papers)Chuanbo Zhang (2 shared papers)Qiang Guo (4 shared papers)
In The Last Decade
Di Ke
33 papers receiving 341 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 85
- Molecular Biology 215
- Pulmonary and Respiratory Medicine 51
- Pharmacology 22
- Management Science and Operations Research 16
Countries citing papers authored by Di Ke
This map shows the geographic impact of Di Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Ke more than expected).
Fields of papers citing papers by Di Ke
This network shows the impact of papers produced by Di Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Ke. The network helps show where Di Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Di Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 85 | |
| 2 | 2018 | 44 | |
| 3 | 2018 | 22 | |
| 4 | Interfering with ITGB1-DT expression delays cancer progression and promotes cell sensitivity of NSCLC to cisplatin by inhibiting the MAPK/ERK pathway. | 2022 | 19 |
| 5 | 2017 | 16 | |
| 6 | 2020 | 16 | |
| 7 | 2019 | 14 | |
| 8 | 2020 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2024 | 9 | |
| 13 | Construction of AP003469.4-miRNAs-mRNAs ceRNA network to reveal potential biomarkers for hepatocellular carcinoma. | 2022 | 9 |
| 14 | 2021 | 7 | |
| 15 | 2018 | 7 | |
| 16 | 2021 | 6 | |
| 17 | ATG10 overexpression is related to the dismal prognosis and promotes the growth and migration of hepatocellular carcinoma cells via cyclin B1/CDK1 and CDK2. | 2023 | 6 |
| 18 | 2023 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2019 | 5 |
About Di Ke
Di Ke is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Organic Chemistry and Oncology, having authored 36 papers that have together received 344 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (5 papers), Electrocatalysts for Energy Conversion (4 papers), Epigenetics and DNA Methylation (4 papers), Chemical Synthesis and Analysis (3 papers), Advanced battery technologies research (3 papers) and Plant biochemistry and biosynthesis (2 papers). The work is most often cited by research in Cancer Research (85 citations), Molecular Biology (215 citations), Pulmonary and Respiratory Medicine (51 citations), Pharmacology (22 citations) and Management Science and Operations Research (16 citations). Di Ke has collaborated with scholars based in China, Australia and Poland. Frequent co-authors include Guojun Jiang, Dan Li, Wenyu Lü, Kai Li, Wei Zhang, Xue Xiao, Chuanbo Zhang, Qiang Guo, Quan Wen and Jie Sun. Their work appears in journals such as Journal of Medicinal Chemistry, Aging, Tetrahedron, Nature Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.